Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Michael Bunn

bmj;395/oct15_11/e101073/F1F1f1Michael was GP partner at the Old Cottage Hospital in Epsom’s Integrated Care Partnership for 26 years. He […]

October 15, 2026 Uncategorized

Wildfire prevention must distinguish ignition from fire weather

Brown documents the severe toxicity of wildfire smoke,1 but prevention also requires asking what ignites fires and what […]

October 15, 2026 Uncategorized

RougeTx launches with $58 million series A financing for HHT therapy

RougeTx launches with  million series A financing for HHT therapy
p p Read More

New company to advance first‑in‑class treatment

October 15, 2026 News

Lundbeck presents phase 1b data for Lu AF28996 in advanced Parkinson’s disease

Lundbeck presents phase 1b data for Lu AF28996 in advanced Parkinson’s disease
p p Read More

Phase 2 development underway as DARE2 trial begins

October 15, 2026 News

Implications of commercial testosterone prescribing for the NHS

The rapid expansion of testosterone prescribing risks broadening treatment from men with well characterised hypogonadism to people with […]

October 15, 2026 Uncategorized

IMIDACLOPRID powder [Jiangsu Tianhe Pharmaceutical Co., Ltd.]

Updated Date: Thu, 08 Oct 2026 00:00:00 EDT

October 15, 2026 Uncategorized

Ketone test strip recall: Hospitals are told to prioritise patients most at risk

Hospitals and ambulance services have been warned that blood ketone testing—vital for patients at risk of diabetic ketoacidosis […]

October 15, 2026 Uncategorized

Palantir: National data guardian writes to ministers warning about FDP

Ministers have been warned by their own independent adviser of potential problems surrounding federated data platform (FDP) and […]

October 15, 2026 Uncategorized

AI bioweapons: how real is the threat?

“We are sleepwalking into a potentially huge disaster,” Ashish Jha, a public health expert who advised the Biden […]

October 14, 2026 Uncategorized

Bespak and SNBL agree global access deal for FDA‑approved nasal device

Bespak and SNBL agree global access deal for FDA‑approved nasal device
p p Read More

Partnership expands Bespak’s intranasal dry powder capabilities

October 14, 2026 News

Posts navigation

« Previous

Posts pagination

1 2 … 2,054 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy